USPTO trademark

SOPHROSYNE PHARMACEUTICALS

RegisteredUSPTOWord markClass 42

"SOPHROSYNE PHARMACEUTICALS" is a word mark owned by Sophrosyne Pharmaceuticals Inc., filed at the USPTO on March 13, 2024. It is registered and covers class 42 (Computer and Scientific Services).

Get this data via the API

Data current as of January 22, 2026Official USPTO record

As filed with the USPTO

Status: Registered; Since October 7, 2025
Filed: March 13, 2024
Registered: October 7, 2025
Expires: Not recorded
Application no.: 98447760
Registration no.: 7978019
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns SOPHROSYNE PHARMACEUTICALS

The owner and representative on file with the office.

Owner

Sophrosyne Pharmaceuticals Inc.

Chicago, United States

Representative

Aric S. Jacover

Jacover Law LLC

Goods and services

What the mark covers

The products and services SOPHROSYNE PHARMACEUTICALS is filed for, grouped by Nice class.

42Class 42 · Computer and Scientific Services
Research and development for FDA-approved prescription medications to address alcohol use disorder (AUD) and other addiction disorders, excluding nutritional supplements

History

What has happened so far

Steps recorded by the USPTO, newest first.

January 21, 2026Automatic update of assignment of ownership
October 7, 2025Notice of registration confirmation emailed
October 7, 2025Registered-principal register
October 3, 2025Notice of registration confirmation emailed
September 15, 2025Notice of acceptance of statement of use e-mailed
September 15, 2025Allowed principal register - sou accepted
August 21, 2025Statement of use processing complete
July 30, 2025Use amendment filed
July 30, 2025Teas statement of use received
July 22, 2025Notice of approval of extension request e-mailed

10 earlier steps on the official record.

FAQ

About SOPHROSYNE PHARMACEUTICALS

Who owns the trademark "SOPHROSYNE PHARMACEUTICALS"?

The USPTO trademark "SOPHROSYNE PHARMACEUTICALS" (application 98447760) is owned by Sophrosyne Pharmaceuticals Inc.

What is the status of "SOPHROSYNE PHARMACEUTICALS"?

Its status at the USPTO is: registered.

When was "SOPHROSYNE PHARMACEUTICALS" registered?

It was registered on October 7, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SOPHROSYNE PHARMACEUTICALS and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2cb0-afd9-74e9-ac14-28f76e824327
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2cb0-afd9-74e9-ac14-28f76e824327",
  "object": "trademark",
  "mark_text": "SOPHROSYNE PHARMACEUTICALS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98447760",
  "filing_date": "2024-03-13",
  "nice_classes": [
    42
  ],
  "owners": [
    {
      "name": "SOPHROSYNE PHARMACEUTICALS INC.",
      "entity_id": null
    }
  ]
}